These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 13642720)

  • 1. [Studies on hyperlipidemia in nephrotic syndrome].
    PEZOLD FA
    Klin Wochenschr; 1959 Feb; 37(3):132-40. PubMed ID: 13642720
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renal origin of hyperlipidemia in nephrotic syndrome].
    REUBI F; SCHMID A
    J Urol Medicale Chir; 1955; 61(5):304-10. PubMed ID: 13307722
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum lipids in nephrotic syndrome.
    Banerjee SK; Sarkar AK; Chugh KS; Bansal VK; Chhuttani PN
    J Assoc Physicians India; 1972 Sep; 20(9):651-8. PubMed ID: 4654886
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperlipidaemia of the nephrotic syndrome--the search for a nephrotic factor.
    Joven J; Vilella E
    Nephrol Dial Transplant; 1995; 10(3):314-6. PubMed ID: 7792024
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperlipoproteinemia in the nephrotic syndrome].
    Yasugi T; Shimizu T; Iijima M; Tomita M; Harada M
    Saishin Igaku; 1972 Mar; 27(3):504-9. PubMed ID: 5021394
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperlipemia in nephrotic syndrome].
    Walasek L
    Pol Tyg Lek; 1972 Jan; 27(5):189-91. PubMed ID: 4551652
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma inhibition of lymphocyte proliferation in nephrotic syndrome: correlation with hyperlipidemia.
    Lenarsky C; Jordan SC; Ladisch S
    J Clin Immunol; 1982 Oct; 2(4):276-81. PubMed ID: 7142366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients.
    D'Amico G; Gentile MG
    Kidney Int Suppl; 1991 Apr; 31():S65-9. PubMed ID: 2046273
    [No Abstract]   [Full Text] [Related]  

  • 9. The hyperlipidemia of the nephrotic syndrome.
    Black RM
    N Engl J Med; 1985 Nov; 313(20):1298-9. PubMed ID: 4058520
    [No Abstract]   [Full Text] [Related]  

  • 10. [Disorders of lipid metabolism in patients with nephrotic syndrome].
    Zdrojewski Z
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):696-9. PubMed ID: 1492041
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent findings on the pathophysiology of hyperlipoidemia in the nephrotic syndrome].
    PEZOLD FA
    Dtsch Arch Klin Med; 1959; 205():640-67. PubMed ID: 14432482
    [No Abstract]   [Full Text] [Related]  

  • 12. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M; Salamatullah Q; Ferdous Z; Hussain MA
    Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of plasma lipid levels by plasma viscosity in nephrotic rats.
    Yedgar S; Eilam O; Shafrir E
    Am J Physiol; 1985 Jan; 248(1 Pt 1):E10-4. PubMed ID: 3966545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood lipids, electrophoretic proteinogram, lipoproteinogram and glycoproteinogram in the development of nephrotic syndrome in children].
    RAMON-GUERRA AU; KORC I; BAUZA CA
    Arch Pediatr Urug; 1959 Jun; 30():342-64. PubMed ID: 14436071
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperlipidemia in the nephrotic syndrome.
    Keane WF; Kasiske BL
    N Engl J Med; 1990 Aug; 323(9):603-4. PubMed ID: 2381446
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperlipidemia and hyperinsulinemia in kidney diseases occurring with the nephrotic syndrome].
    Razboinikov S; Tishkov I; Shipkova P; Turkolov N; Mushmov D
    Urol Nefrol (Mosk); 1979; (4):19-23. PubMed ID: 473433
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dyslipidemias and nephropathies].
    Mioli V; Pacchiarotti P; Lombardo L; De Vizia L; Perilli A; Sprovieri G; Recchioni A; Marchesi V
    Minerva Med; 1975 Oct; 66(66):3449-53. PubMed ID: 1178135
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of hyperlipidemia in adults with nephrotic syndrome.
    Khanna UB; Nerurkar SV; Almeida AF; Taskar SP; Acharya VN
    J Postgrad Med; 1985 Jul; 31(3):140-5. PubMed ID: 4087215
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA; Davies RW
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pravastatin on serum lipids and apolipoproteins in hyperlipidemia of the nephrotic syndrome.
    Tokoo M; Oguchi H; Terashima M; Tokunaga S; Miyasaka M; Hora K; Higuchi M; Yoshie T; Furuta S
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):397-403. PubMed ID: 1635284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.